The Han Lab Publications

Selected Publications

Lead Authorship
Middle Authorship

Choi, E., Ding, V.Y., Luo, S.J., ten Haaf, K., Wu, J.T. Aredo, J.V., Wilkens, L.R., Freedman, N.D., Backhus, L.M.,Leung, A.N., Meza R., Lui, N. S., Haiman, C.A., Park, S.L., LLe Marchand, L., Neal, J.W., Cheng, I., Wakelee, H.A., Tammemägi, M.C., and Han, S.S. (2023) Risk Model–Based Lung Cancer Screening and Racial and Ethnic Disparities in the US. JAMA Oncology

*Fries, A.H., *Choi, E., Wu, J.T., Lee, J.H., Ding, V.Y., Huang, R.J., Liang, S.Y., Wakelee, H.A., Wilkens, L.R., Cheng, I. and Han, S.S., (2023) Software Application Profile: dynamicLM—a tool for performing dynamic risk prediction using a landmark supermodel for survival data under competing risks. International Journal of Epidemiology, p.dyad122.

*Choi, E., *Su, C.C., Wu, J.T., Aredo, J.V., Neal, J.W., Leung, A. N., Backhus, L.M., Lui, N.S., Le Marchand, L., Stram, D.O., Liang, S.Y., Cheng, I., Wakelee, H.A., Han, S.S. (2023) Second Primary Lung Cancer among Lung Cancer Survivors Who Never Smoked. JAMA Network Open. 6 (11), e2343278-e2343278

Choi E., Luo, S.J. Ding, V.Y., Wu, J.T., Kumar, A.V., Wampfler, J., Tammemägi, M.C., Wilkens, L.R., Aredo, J.V., Backhus, L.M., Neal, J.W.,Leung, A. N., Freedman, N.D., Hung, R. J., Amos, C.I., Le Marchand, L., Cheng, I., Wakelee, H.A., Yang, P., and Han, S.S. (2023) Risk Model-Based Management for Second Primary Lung Cancer Among Lung Cancer Survivors Through A Validated Risk Prediction Model. Cancer

Su, C.C., Wu, J.T., Choi, E., Myall, N.J., Neal, J.W., Kurian, A.W., Stehr, H., Wood, D., Henry, S.M., Backhus, L.M. Leung, A.N., Wakelee, H.A, and Han, S.S. (2023) Overall Survival Among PatientsWith De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung Cancer. JAMA Network Open, 6(9), pp.e2335813-e2335813.

Wu, J.T.Y., Wakelee, H.A. and Han, S.S., (2023) Optimizing Lung Cancer Screening With Risk Prediction: Current Challenges and the Emerging Role of Biomarkers. Journal of Clinical Oncology, pp.JCO-23.

Toumazis, I., Cao*, P., de Nijs*, K., Bastani*, M., Munshi, V., Hemmati, M., ten Haaf, K., Jeon, J., Tammemägi, M., Gazelle, G.S., Feuer, E.J., Kong, C.Y., Meza, R., de Koning, H.J. Plevritis, S.K., and Han, S.S. (2023) Risk Model–Based Lung Cancer Screening: A Cost-Effectiveness Analysis. Annals of Internal Medicine

Wu, J., Ding, V., Luo, S., Choi, E., Hellyer, J., Myall, N., Henry, S., Wood, D., Stehr, H., Ji, H. and Nagpal, S., Gephart, M., Wakelee, H., Neal, J., and Han, S.S. 2022. Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes. JCO Precision Oncology, 6, p.e2200220.

Aredo, J.V., Choi, E., Ding, V.Y., Tammemägi, M.C., Ten Haaf, K., Luo, S.J., Freedman, N.D., Wilkens, L.R., Le Marchand, L., Wakelee, H.A. and Meza, Park, S., Cheng, I., Han, S.S. 2022. Racial and ethnic disparities in lung cancer screening by the 2021 USPSTF guidelines versus risk-based criteria: the Multiethnic Cohort Study. JNCI Cancer Spectrum, 6(3), p.pkac033.

*Choi, E., *Luo, S.J., Aredo, J.V., Backhus, L.M., Wilkens, L.R., Su, C.C., Neal, J.W., Le Marchand, L., Cheng, I., Wakelee, H.A. and Han, S.S. (2021) The Survival Impact of Second Primary Lung Cancer in Patients with Lung Cancer. JNCI: Journal of the National Cancer Institute.

Toumazis, I., de Nijs, K., Cao, P., Bastani, M., Munshi, V., Ten Haaf, K., Jeon, J., Gazelle, G.S., Feuer, E.J., de Koning, H.J., Meza, R., Kong, C., *Han S.S., *Plevritis, S.K. (2021) Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening. JAMA oncology. *Co-Corresponding Authors

Choi, E., Sanyal, N., Ding, V.Y., Gardner, R.M., Aredo, J.V., Lee, J., Wu, J.T., Hickey, T.P., Barrett, B., Riley, T.L., Wilkens, L.R., Leung, A.N., Le Marchand, L., Tammemägi, M., Hung, R.J., Amos, C.I., Freedman, N.D., Cheng, I., Wakelee, H.A., Han, S.S. (2021) Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer. Journal of National Cancer Institute

Aredo, J.V., Wakelee, H.W., Han, S.S. (2021) A Moving Target: Integration of Smoking Cessation into Screening for Second Primary Lung Cancer. Journal of Thoracic Oncology (Letter to the editor)

Su, C.C., Wu., J.T., Neal, J.W., Popat, R.A., Kurian, A.W., Backhus, L.M., Nagpal S., Leung, A.N., Wakelee, H.A., Han, S.S., (2021) Impact of Low-Dose CT Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis. Journal of Thoracic Oncology

Aredo, J.V., Luo, S., Gardner, R.M., Sanyal, N., Choi, E., Hickey, T.P., Riley, T.L., Huang, W., Kurian, A.W., Leung, A.N., Wilkens, L.R., Le Marchand, L., Amos, C.I., Hung, R.J., Freedman, N.D., Johansson, M., Robbins, H.A., Riboli, E., Rudolf Kaaks, R., Tjønneland A., Vermeulen, R.C.H., Panico, S., Cheng, I., Wakelee, H.W., Han, S.S. (2021) Tobacco Smoking and Risk of Second Primary Lung Cancer. Journal of Thoracic Oncology

Luo, S.J., Choi, E., Aredo, J.V., Wilkens, L.R., Tammemägi, M.C., Le Marchand, L., Cheng, I., Wakelee, H.A. and Han, S.S., 2021. Smoking Cessation After Lung Cancer Diagnosis and the Risk of Second Primary Lung Cancer: The Multiethnic Cohort Study. JNCI cancer spectrum, 5(5), p.pkab076.

Sanyal, N., Napolioni, V., de Rochemonteix, M., Belloy,M.E., Caporaso, N.E., Landi, M.T., Michael D. Greicius, M.D., Chatterjee, N., Han, S.S. (2021) A robust test for additive gene-environment interaction under the trend effect of genotype using an empirical Bayes-type shrinkage estimator. American Journal of Epidemiology

Aredo, J. V., Purington, N., Su, L., Luo, S. J., Diao, N., Christiani, D. C., Wakelee*, H. A, Han, S.S* Metabolomic Profiling for Second Primary Lung Cancer: A Pilot Case-Control Study. (2021) Lung Cancer

de Rochemonteix, M., Napolioni, V., Sanyal, N., Belloy M.E., Caporaso, Landi, M.T., Greicius, M.D., Chatterjee, N., and Han, S.S. (2020) A likelihood ratio test for gene-environment interaction based on the trend effect of genotype under an additive risk model using the gene-environment independence assumption. American Journal of Epidemiology.

Han, S.S., Chow, E., ten Haaf, K., Toumazis, I., Bastani, M., Tammemagi. M., Jeon, J., Meza, R., Plevritis, S.K. (2020) Disparities and national lung screening guidelines in the U.S. population. Journal of National Cancer Institute.

Han, S.S., Azad, T.D., Suarez, P.A. and Ratliff, J.K., (2019) A machine learning approach for predictive models of adverse events following spine surgery. The Spine Journal.

Han, S.S., Kelly, S.P., Yang, B., Li, Y., Nguyen, M.H., So, S.K , Rosenberg, P.S., and Hsing, A.W., (2018) Changing landscape of liver cancer in California: a glimpse into the future of liver cancer in the United States. Journal of the National Cancer Institute.

Han, S.S., Plevritis, S.K. and Wakelee, H.A., (2018) Caution Needed for Analyzing the Risks of Second Cancers. Journal of Thoracic Oncology, 13(9), pp.e172-e173

Han, S. S., & Chatterjee, N. (2018). Review of Statistical Methods for Gene-Environment Interaction Analysis. Current Epidemiology Reports, 1-7.

Han, S. S., Kevin ten Haaf, WD Hazelton, J Jeon, RMeza, CY Kong, EJ Feuer, HJ de Koning, SK Plevritis (2017) Re: Think Before You Leap International Journal of Cancer (In press)

Han, S.S., Raymond J. Carroll, and Nilanjan Chatterjee (2017) Book Chapter: Analysis of Gene- Environment Interactions; Handbook of Statistical Methods for Case-Control Studies (Chapman & Hall) (In Press)

Han, S.S., Rivera G.A.,Tammemägi M.C., Plevritis S.K., Cheng I, Gomez S.L., Wakelee H.A. Risk-Stratification for Second Primary Lung Cancer. (2017) Journal of Clinical Oncology

Han, S. S., I. Toumazis, S. A. Erdogan, A. Leung & S. K. Plevritis (2017) Evaluating the Impact of Varied Compliance to Lung Cancer Screening Recommendations using a Microsimulation Model. Cancer Causes and Control.

Han, S. S., K. ten Haaf, W. D. Hazelton, V. N. Munshi, J. Jeon, S. A. Erdogan, C. Johanson, P. M. McMahon, R. Meza & C. Y. Kong (2017) The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. International Journal of Cancer.

Eckhert, E., Lansinger, O., Ritter, V., Liu, M., Han, S., Schapira, L., John, E.M., Gomez, S., Sledge, G. and Kurian, A.W., (2023) Breast cancer diagnosis, treatment, and outcomes of patients from sex and gender minority groups. JAMA Oncology, 9(4), pp.473-480.

Ransohoff, J.D., Ritter, V., Purington, N., Andrade, K., Han, S., Liu, M., Liang, S.Y., John, E.M., Gomez, S.L., Telli, M.L. and Schapira, L., (2023) Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer. Nature Communications, 14(1), p.2053.

Dadey, D.Y., Medress, Z.A., Sharma, M., Ugiliweneza, B., Wang, D., Rodrigues, A., Parker, J., Burton, E., Williams, B., Han, S.S. and Boakye, M., (2023) Risk of developing glioblastoma following non- CNS primary cancer: a SEER analysis between 2000 and 2018. Journal of Neuro-Oncology, pp.1-8.

Rodrigues, A.J., Medress, Z.A., Sayadi, J., Bhambhvani, H., Falkson, S.R., Jokhai, R., Han, S.S. and Hong, D.S., (2023) Predictors of spine metastases at initial presentation of pediatric brain tumor patients: a single-institution study. Child's Nervous System, 39(3), pp.603-608.

Gupta, T., Purington, N., Liu, M., Han, S., Sledge, G., Schapira, L. and Kurian, A.W., (2022) Incident comorbidities after tamoxifen or aromatase inhibitor therapy in a racially and ethnically diverse cohort of women with breast cancer. Breast Cancer Research and Treatment, 196(1), pp.175-183.

Almeda, A.F., Grimes, S.M., Lee, H., Greer, S., Shin, G., McNamara, M., Hooker, A.C., Arce, M.M., Kubit, M., Schauer, M.C. and Van Hummelen, P., Han, S.S., Huang R., Ji, H. (2022) The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer. Cancer Epidemiology, Biomarkers & Prevention, 31(9), pp.1693-1700.

Meza, R., Jeon, J., Toumazis, I., Ten Haaf, K., Cao, P., Bastani, M., Han, S.S., Blom, E.F., Jonas, D.E., Feuer, E.J. and Plevritis, S.K., 2021. Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force. JAMA, 325(10), pp.988-997.

Aredo, J.V., Mambetsariev, I., J. A. Hellyer, A. Amini, J. W. Neal, S. K. Padda, C. E. McCoach, J. W. Riess, E. C. Cabebe, J. Naidoo, T. Abuali, R. Salgia, B. W. Loo, M. Diehn, Han, S.S. & H. A. Wakelee, 2021. Durvalumab for Stage III EGFR-mutated Non-small Cell Lung Cancer After Definitive Chemoradiotherapy. Journal of Thoracic Oncology.

Fatemi, P., Zhang, Y., Han, S.S., Purington, N., Zygourakis, C.C., Veeravagu, A., Desai, A., Park, J., Shuer, L.M. and Ratliff, J.K., 2021. External validation of a predictive model of adverse events following spine surgery. The Spine Journal.

Jin, M.C., Sussman, E.S., Feng, A.Y., Han, S.S., Skirboll, S.L., Berube, C. and Ratliff, J.K., 2021. Hemorrhage risk of direct oral anticoagulants in real-world venous thromboembolism patients. Thrombosis Research, 204, pp.126-133.

Bigder, M., Choudhri, O., Gupta, M., Gummidipundi, S., Han, S.S., Church, E.W., Chang, S.D., Levy, R.P., Do, H.M., Marks, M.P. and Steinberg, G.K., 2021. Radiosurgery as a microsurgical adjunct: outcomes after microsurgical resection of intracranial arteriovenous malformations previously-5- treated with stereotactic radiosurgery. Journal of Neurosurgery, 1(aop), pp.1-12.

Caswell-Jin, J.L., Callahan, A., Purington, N., Han, S.S., Itakura, H., John, E.M., Blayney, D.W., Sledge Jr, G.W., Shah, N.H. and Kurian, A.W., 2021. Treatment and Monitoring Variability in US Metastatic Breast Cancer Care. JCO Clinical Cancer Informatics, 5, pp.600-614.

Belloy, M.E., Eger, S.J., Le Guen, Y., Napolioni, V., Deters, K.D., Yang, H.S., Scelsi, M.A., Porter, T., James, S.N., Wong, A. and Schott, J.M…., Han, S.S., Altmann, A., Greicius, M.D., 2021. KL* VS Heterozygosity Reduces Brain Amyloid in Asymptomatic at Risk APOE* 4 Carriers. Neurobiology of Aging.

Toumazis, I., Bastani, M., Han, S.S. and Plevritis, S.K., 2020. Risk-Based lung cancer screening: A systematic review. 2020. Lung Cancer.

Li, Y., Khahera, A., Kim, J., Mandel, M., Han, S.S. and Steinberg, G.K., 2021. Basal ganglia cavernous malformations: case series and systematic review of surgical management and long-term outcomes. Journal of Neurosurgery, 1(aop), pp.1-9.

Church, E.W., Bell-Stephens, T.E., Bigder, M.G., Gummidipundi, S., Han, S.S. and Steinberg, G.K., 2020. Clinical course of unilateral moyamoya disease. 2020. Neurosurgery.

Nielsen, T.H., Abhinav, K., Sussman, E.S., Han, S.S., Weng, Y., Bell-Stephens, T., Heit, J.J. and Steinberg, G.K., 2020. Direct versus indirect bypass procedure for the treatment of ischemic moyamoya disease: results of an individualized selection strategy. Journal of Neurosurgery, 1(aop), pp.1-12.

Jin, M.C., Ho, A.L., Feng, A.Y., Zhang, Y., Staartjes, V.E., Stienen, M.N., Han, S.S., Veeravagu, A., Ratliff, J.K. and Desai, A.M., 2020. Predictive modeling of long-term opioid and benzodiazepine use after intradural tumor resection. The Spine Journal.

Sussman, E.S., Gummidipundi, S.E., Pendharkar, A.V., Church, E.W., Ho, A.L., Han, S.S. and Steinberg, G.K., 2020. Staged Surgical Resection of Brain Arteriovenous Malformations. World neurosurgery.

Church, E.W., Bigder, M.G., Sussman, E.S., Gummidipundi, S.E., Han, S.S., Heit, J.J., Do, H.M., Dodd, R.L., Marks, M.P. and Steinberg, G.K., 2020. Treatment of posterior circulation fusiform aneurysms. Journal of Neurosurgery, 1(aop), pp.1-7.

Fatima, N., Ding, V.Y., Han, S.S., Chang, S.D. and Meola, A., 2020. Predictors of visual functional outcome following treatment for cavernous sinus meningioma. Journal of Neurosurgery, 1(aop), pp.1-12.

Mahajan, U.V., Purger, D.A., Mantovani, A., Williams, N.R., Espil, F.M., Han, S.S., Stein, S.C. and Halpern, C.H., 2020. Deep Brain Stimulation Results in Greater Symptomatic Improvement in Tourette Syndrome than Conservative Measures: A Meta-Analysis. Stereotactic and Functional Neurosurgery, 98(4), pp.270-277.

Tammemägi, M., Haaf, K ten, Toumazis, I., Kong, C.Y., Han, S.S., Jeon, J., Commins, J., Riley T., Meza, R. 2019. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model Including CT Screening Results – A Secondary Analysis of Data from the National Lung Screening Trial. JAMA Network Open, 2 (3), e190204-e190204.

Lin, C.Y., Vennam, S., Purington, N., Lin, E., Varma, S., Han, S., Desa, M., Seto, T., Wang, N.J., Stehr, H. and Troxell, M.L., 2019. Genomic landscape of ductal carcinoma in situ and association with progression. Breast cancer research and treatment, 178(2), pp.307-316.

Gray, M., Adamson, M.M., Thompson, R.C., Kapphahn, K.I., Han, S., Chung, J.S. and Harris, O.A., 2020. Sex differences in symptom presentation and functional outcomes: a pilot study in a matched sample of veterans with mild TBI. Brain injury, 34(4), pp.535-547.

Ten Haaf, K., Bastani, M., Cao, P., Jeon, J., Toumazis, I., Han, S.S., Plevritis, S.K., Blom, E.F., Kong, C.Y., Tammemägi, M.C. and Feuer, E.J., 2020. A comparative modeling analysis of risk-based lung cancer screening strategies. JNCI: Journal of the National Cancer Institute.

Belloy, M.E., Napolioni, V., Han, S.S., Le Guen, Y. and Greicius, M.D., 2020. Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4. JAMA Neurology.

Abhinav, K., Nielsen, T.H., Singh, R., Weng, Y., Han, S.S., Iv, M. and Steinberg, G.K., 2020. Utility of a Quantitative Approach Using Diffusion Tensor Imaging for Prognostication Regarding Motor and Functional Outcomes in Patients With Surgically Resected Deep Intracranial Cavernous Malformations. Neurosurgery, 86(5), pp.665-675.

Church, E.W., Qaiser, R., Bell-Stephens, T.E., Bigder, M.G., Chow, E.K., Han, S.S., El-Sayed, Y.Y. and Steinberg, G.K., 2019. Pregnancy after direct cerebral bypass for moyamoya disease. Journal of neurosurgery, 1(aop), pp.1-7.

Toumazis, I., Tsai, E.B., Erdogan, S.A., Han, S.S., Wan, W., Leung, A. and Plevritis, S.K., 2019. Cost-Effectiveness Analysis of Lung Cancer Screening Accounting for the Effect of Indeterminate Findings. JNCI Cancer Spectrum, 3(3), p.pkz035.

Abhinav, K., Furtado, S.V., Nielsen, T.H., Iyer, A., Gooderham, P.A., Teo, M., Lee, J., Han, S.S., Gary K Steinberg, Functional Outcomes after Revascularization Procedures in patients with Hemorrhagic Moyamoya disease. Neurosurgery.

Hsing, J.C., Nguyen, M.H., Yang, B., Min, Y., Han, S.S., Pung, E., Winter, S.J., Zhao, X., Gan, D., Hsing, A.W. and Zhu, S., 2019. Associations Between Body Fat, Muscle Mass, and Nonalcoholic Fatty Liver Disease: A Population‐Based Study. Hepatology Communications.

Yu, X., Guo, H., Liu, X., Wang, G., Min, Y., Chen, S.H.S., Han, S.S., Chang, R.T., Zhao, X., Hsing, A. and Zhu, S., 2019. Dry eye and sleep quality: a large community-based study in Hangzhou. Sleep.

Liu, J.J., Nielsen, T.H., Abhinav, K., Lee, J., Han, S.S., Marks, M.P., Do, H.M., Dodd, R.L. and Steinberg, G.K., 2019. Surgical Treatment of Recurrent Previously Coiled and/or Stent-Coiled Intracerebral Aneurysms: A Single-Center Experience in a Series of 75 Patients. World neurosurgery, 124, e649-e658.

Aredo, J.V., Padda, S.K., Kunder, C.A., Han, S.S., Neal, J.W., Shrager, J.B. and Wakelee, H.A., 2019. Response to comment on “Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes”. Lung Cancer, 137, pp.159-160.

Huang, Y., Chow, K.K., Aredo, J.V., Padda, S.K., Han, S.S., Kakusa, B.W. and Gephart, M.H., 2019. Epidermal Growth Factor Receptor Mutation Status Confers Survival Benefit in Patients with Non-Small-Cell Lung Cancer Undergoing Surgical Resection of Brain Metastases: A Retrospective Cohort Study. World neurosurgery, 125, pp.e487-e496.

Aredo, J.V., Padda, S.K., Kunder, C.A., Han, S.S., Neal, J.W., Shrager, J.B. and Wakelee, H.A., 2019. Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes. Lung Cancer, 133, pp.144-150.

Kakusa, B., Han, S., Aggarwal, S., Liu, B., Li, G., Soltys, S. and Gephart, M.H., 2018. Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer. Journal of neuro-oncology, pp.1-11. Provided principal statistical analytic plans and oversaw implementation of analysis.

Azad, T., Vail, D., Bentley, J., Han, S., Suarez, P., Varshneya, K., Mittal, V., Veeravagu, A., Desai, M., Bhattacharya, J. and Ratliff, J., 2018. Initial Provider Specialty is Associated with Long-term Opiate Use in Patients with Newly Diagnosed Low Back and Lower Extremity Pain. Spine. 44 (3), 211-218.

Yang, B., Liu, J.B., So, S.K., Han, S.S., Wang, S.S., Hertz, A., Shariff‐Marco, S., Lin Gomez, S., Rosenberg, P.S., Nguyen, M.H. and Hsing, A.W., 2018. Disparities in Hepatocellular Carcinoma Incidence by Race/Ethnicity and Geographic Area in California: Implications for Prevention. Cancer.

Azad, T., Vail, D., Bentley, J., Han, S., Suarez, P., Varshneya, K., Mittal, V., Veeravagu, A., Desai, M., Bhattacharya, J. and Ratliff, J., 2018. Initial Provider Specialty is Associated with Long-term Opiate Use in Patients with Newly Diagnosed Low Back and Lower Extremity Pain. Spine.

Dougan, M.M., Li, Y., Chu, L.W., Haile, R.W., Whittemore, A.S., Han, S.S., Moore, S.C., Sampson, J.N., Andrulis, I.L., John, E.M. and Hsing, A.W., 2018. Metabolomic profiles in breast cancer: a pilot case-control study in the breast cancer family registry. BMC cancer, 18(1), p.532.

Chu, L.W., Till, C., Yang, B., Tangen, C.M., Goodman, P.J., Yu, K., Zhu, Y., Han, S.S., Hoque, A.M., Ambrosone, C. and Thompson, I., (2018). Circadian Genes and Risk of Prostate Cancer in the Prostate Cancer Prevention Trial. Molecular carcinogenesis.

Pollom, E. L., Fujimoto, D. K., Han, S. S., Harris, J. P., Tharin, S. A., & Soltys, S. G. (2018). Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival. Journal of radiation research.

Vail, D., Azad, T. D., O'Connell, C., Han, S. S., Veeravagu, A., & Ratliff, J. K. (2017). Postoperative Opioid Use, Complications, and Costs in Surgical Management of Lumbar Spondylolisthesis. Spine.

Christopher L, Napolioni V., Khan R.R., Han S.S., Michael D. Greicius for the Alzheimer's Disease Neuroimaging Initiative (2017) A variant in PPP4R3A protects against alzheimer-related metabolic decline. Annals of Neurology

Ten Haaf, K., J. Jeon, M. C. Tammemägi, S. S. Han, C. Y. Kong, S. K. Plevritis, E. J. Feuer, H. J. de Koning, E. W. Steyerberg & R. Meza (2017) Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. PLoS Medicine, 14, e1002277.

The Han Lab

Find a doctor

Clinics & Services

Research Resources

Professional Training

Education Resources

The Han Lab Publications

Selected Publications

Featured Publications

Resources